BioSpace News Archive

Deals

Sorrento Therapeutics, Inc.'s Bankruptcy Court Approves Elective Offering of Restricted Common Stock of Scilex Holding Company for Dividend Short Holders

Sorrento Therapeutics, Inc. announced that, in connection with its ongoing chapter 11 case, the U.S. Bankruptcy Court for the Southern District of Texas entered an order approving an offering of a portion of Sorrento’s common stock in its non-debtor public subsidiary, Scilex Holding Company.

July 20, 2023
·
6 min read
Genetown

Biostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)

Biostage, Inc. (OTCQB: formerly BSTG) announced today it has changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and trade under the OTCQB symbol “HRGN” effective July 20, 2023.

July 20, 2023
·
4 min read
Biotech Bay

23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin

23andMe Holding Co. released a new Simvastatin Medication Insight report as part of its 23andMe+ membership service that reports on a person’s likelihood of experiencing side effects from this commonly prescribed statin drug.

July 20, 2023
·
7 min read
Co-Diagnostics, Inc. to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim, CA

Co-Diagnostics, Inc. announced today that it is hosting a booth at the American Association for Clinical Chemistry (AACC) annual meeting and expo held July 23-27, 2023.

July 20, 2023
·
3 min read
EASEE(R) Receives a “Shark Tank” Innovation Award from the Epilepsy Foundation

EASEE®, the world’s first minimally invasive brain pacemaker, presented by Angela Liedler, CEO of Heidelberg-based Precisis, has been awarded top prize in this year’s ‘Shark Tank’ competition run by the Epilepsy Foundation.

July 20, 2023
·
3 min read
Business

Premier Anesthesia Announces the Appointment of Two Regional Medical Directors

Premier Anesthesia, a national leader and specialist in anesthesia practice management, has announced the promotions of Miguel Cervantes III, MD, MBA, FASA, and Anthony Dominic, DO, MHSA to the positions of regional medical directors.

July 20, 2023
·
3 min read
ABL enters seven-year multimillion dollar contract with NIH for Diagnostics Preclinical Services program

Advanced BioScience Laboratories (ABL), a global Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) serving the US Government and biopharmaceutical industry

July 20, 2023
·
3 min read
Policy

Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites

Boehringer Ingelheim announced that the U.S. Food and Drug Administration has approved the newest innovation from the trusted NexGard® Brand of Products — NexGard® PLUS — a monthly beef-flavored soft chew that protects dogs from fleas, ticks, heartworm disease, roundworms and hookworms.

July 20, 2023
·
7 min read
BioCapital

CEL-SCI Announces Closing of Public Offering - July 20, 2023

CEL-SCI Corporation announced the closing of its previously announced public offering of 2,500,000 shares of its common stock at a public offering price of $2.00 per share, for gross proceeds of $5,000,000, before deducting underwriting discounts and offering expenses.

July 20, 2023
·
3 min read
Business

Guerbet: First-half 2023 revenue

Guerbet, a global specialist in contrast agents and solutions for medical imaging, is reporting its revenue for the first half of 2023.

July 20, 2023
·
9 min read